About This Test
BCR-ABL is a fusion gene formed by the rearrangement of breakpoint cluster region (BCR) on chromosome 22 with the ABL protooncogene on chromosome 9 leading to the formation of Philadelphia chromosome. This rearrangement is seen in almost 95% patients with CML. The Quantitative assay helps in the management of the disease and monitors effect of therapy. This test detects Major, Minor and Micro BCR-ABL translocation.
Test Parameters (1)
- BCR-ABL PCR, QUANTITATIVE
Home Collection
✓ Available
Reports Available In
2 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
This test is important for diagnosing, monitoring, and guiding targeted treatment of BCR-ABL positive leukemias.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
